Show simple item record

dc.contributor.authorMeyer, Marc H.
dc.contributor.authorFriar, John H.en
dc.contributor.authorKursh, Steven R.en
dc.contributor.authorShaughnessy, Dennisen
dc.date.accessioned2024-01-26T17:11:43Z
dc.date.available2024-01-26T17:11:43Z
dc.date.issued2008
dc.identifier.citationMarc H. Meyer, John H. Friar, Steven R. Kursh, Dennis Shaughnessy, 'BioBlood: M&A in the Biotech World', Senate Hall, 2008, International Journal of Entrepreneurship Education, 75-100
dc.identifier.issn1649-2269
dc.description.abstractThe case focuses on the process of discovery, valuation, and deal structure in the acquisition of a small privately held company by a much larger company, both in the biotechnology industry. The case is written from the perspective of the head of business development for the larger company, William O'Brien. The case also provides richer details in how an acquirer prepares and structures a bid.en
dc.language.isoenen
dc.publisherSenate Hallen
dc.relation.ispartofseriesInternational Journal of Entrepreneurship Educationen
dc.relation.haspartVol. 6, Issue 2, 2008eng
dc.rightsY
dc.sourceInternational Journal of Entrepreneurship Education
dc.subjectbiotechnology|case study|venture acquisition|deal structureen
dc.titleBioBlood: M&A in the Biotech World
dc.typeJournal article
dc.status.refereedYes
dc.publisher.placeDublin
dc.rights.ecaccessrightsopenAccess
dc.format.extentpagination75-100
dc.identifier.urihttp://hdl.handle.net/2262/104483


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record